Travere Therapeutics, Inc.
TVTX
Revenue
129.69M
▼-35.17M▼-21.33%
3 Months ChangeAssets
605.19M
▲66.61M▲12.37%
3 Months ChangeLiabilities
490.36M
▲25.35M▲5.45%
3 Months ChangeFree Cash Flow
-119.01M
▼-37.26M▼-45.58%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-19
Form 8-K
ID: 0001438533-26-000013
2026-01-13
Form 8-K
ID: 0001438533-26-000005
2026-01-12
Form 8-K
ID: 0001438533-26-000003
2025-10-30
Form 10-Q
ID: 0001438533-25-000056
2025-10-30
Form 8-K
ID: 0001438533-25-000055
2025-09-10
Form 8-K
ID: 0001438533-25-000049
2025-08-06
Form 10-Q
ID: 0001438533-25-000046
2025-08-06
Form 8-K
ID: 0001438533-25-000045
2025-05-16
Form 8-K
ID: 0001438533-25-000034
2025-05-15
Form 8-K
ID: 0001438533-25-000032